Sales rise 4.65% to Rs 836.26 crore
Net profit of Glaxosmithkline Pharmaceuticals rose 31.84% to Rs 130.32 crore in the quarter ended September 2017 as against Rs 98.85 crore during the previous quarter ended September 2016. Sales rose 4.65% to Rs 836.26 crore in the quarter ended September 2017 as against Rs 799.12 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales836.26799.12 5 OPM %22.9717.61 -PBDT201.70158.82 27 PBT193.97152.24 27 NP130.3298.85 32Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content